01—History
Gross Profit History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2026. Drag across the bars to change the range.
- $2.24B
1 older move runs past ±150% (largest +1214.5%); point at, tap or drag across the bars to read one.
02—Ledger
Gross Profit, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2026 | $2.24B | +6.9% | 10-K | |
| FY2025 | $2.09B | +19.0% | 10-K | |
| FY2023 | $1.76B | +13.2% | 10-K | |
| FY2022 | $1.55B | +12.4% | 10-K | |
| FY2021 | $1.38B | +47.9% | 10-K | |
| FY2020 | $934.7M | +13.0% | 10-K | |
| FY2018 | $827.5M | +89.2% | 10-K | |
| FY2017 | $437.4M | +1214.5% | 10-K | |
| FY2016 | $33.3M | 0.0%flat | 10-K | |
| FY2015 | $33.3M | +44.3% | 10-K | |
| FY2014 | $23.1M | −23.7% | 10-K | |
| FY2013 | $30.2M | −36.3% | 10-K | |
| FY2012 | $47.5M | −83.6% | 10-K | |
| FY2011 | $289.6M | — | 10-K |
03—Questions
What is gross profit?
Gross profit can be defined as revenue minus the cost of goods sold, representing the profit a company makes before deducting operating expenses.
What is Exelixis's current gross profit?
Exelixis (EXEL) annual gross profit for 2026 was $2.24B, a 6.88% increase from 2025. Exelixis gross profit for the quarter ending October 2, 2026 was $632.5M.
What was Exelixis's gross profit in 2025?
Exelixis annual gross profit for 2025 was $2.09B, a 19.05% increase from 2023.
What was Exelixis's gross profit in 2023?
Exelixis annual gross profit for 2023 was $1.76B, a 13.17% increase from 2022.
What is Exelixis's 5-year gross profit CAGR?
Exelixis gross profit grew at a compound annual growth rate (CAGR) of 10.10% from FY2021 to FY2026, going from $1.38B to $2.24B over 5 years.
- Company
- Exelixis
- Ticker
- EXEL
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)